Cell Culture Dish Podcast

Latest Episodes
Mesenchymal Stem Cell Culture – Challenges and solutions for isolation, expansion and maintenance
Challenges and solutions for isolation, expansion and maintenance
CryoVault Freeze and Thaw Platform Provides a Scalable, Robust and Single-Use End-to-End Solution for Bulk Drug Substance
In this podcast, I talked with Max Blomberg, Executive Director of Operations and Andrew Govea, Senior Product Engineer, Meissner about the challenges of handling bulk drug substance, specifically fr
Generating actionable data and analysis in complex models using live-cell analysis
Benefits of real-time live-cell analysis and image processing workflows
Improved gene therapy analytics permit monitoring of critical quality attributes and increased manufacturing efficiency
Jonathan Royce, Director, Instruments Business Unit, Vironova talks about analytics in gene therapy manufacturing. Specifically, Jonathan details new technologies to monitor critical quality attributes, reduce development time and increase the number o...
New Advancements in Cell and Gene Therapy Implementing Precision Medicine
Discussion included Obsidian's cytoDRiVE platform that provides a technology, in which the level and timing of protein activity are fully controlled in a dose-dependent manner by an FDA-approved smal
Live Cell Analysis for Neuroscience Research
Susana Alcantara, Senior R&D Scientist and Neuroscience Program Leader, BioAnalytics, Sartorius talks about the ways real-time live-cell analysis is enabling neuroscience research.
Using 3D cell-based human liver microtissue models in predicting adverse effects caused by chronic exposure to engineered nanomaterial
Shareen Doak andDr. Wolfgang Moritz talk aboutthe use of 3D cell-based human liver microtissue models to predict the adverse effects of chronic exposure to nanomaterial . We also discussed the use o
Raw Material Quality – Identifying and Mitigating Variation
Cory Card, Principal Scientist Life Sciences, GE Healthcare about raw material quality, its impact on cell culture and technologies to identify and mitigate raw material variation.
Antibody Drug Conjugate (ADC) Development and Manufacturing Challenges and Solutions
In thispodcast, we interviewedDr. J.J. Luo,Executive DirectorandDr. Lily Yin, Head of Biologics Conjugation Development,at WuXi Biologics about the state of the ADC marketplace and the challenge
Mustang Bio’s gene therapy has tremendous potential to cure XSCID or Bubble Boy Disease based on study results from St. Jude
We interviewedDr. Manny Litchman,President and CEO, Mustang Bio and Dr. Knut Niss, Chief Technology Officer, Mustang Bioabout the exciting study results for their gene therapy candidate to treat XS